Lincoln Pharmaceuticals P/B Ratio
Lincoln Pharmaceuticals P/B ratio. Lincoln Pharmaceuticals (LINCOLN) P/B ratio is 1.54 (Moderate), book value per share ₹379.00 vs Healthcare average P/B of 0.01 — Moderate - Reasonably valued relative to book value. For live price, earnings yield and the full fundamental profile, see Lincoln Pharmaceuticals screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
LINCOLN P/B Ratio — Valuation Insights & Book Value Analysis
Lincoln Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 1.54 (Moderate). View LINCOLN yearly price range for the annual high/low range and current price position.
- Current PB is 20.3% below historical average
- Trading at premium to sector average PB of 0.01
Lincoln Pharmaceuticals P/B Ratio Historical Trend
LINCOLN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Analyse Lincoln Pharmaceuticals ownership structure to track promoter, FII and institutional holdings.
LINCOLN Historical P/B Ratio — Book Value Per Share & Year-End Price
Lincoln Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.5 | ₹379.0 | ₹567.20 | ₹758 | Moderate |
| 2025 | 1.44 | ₹336.0 | ₹483.95 | ₹672 | Moderate |
| 2024 | 2.66 | ₹296.5 | ₹787.80 | ₹593 | Moderate |
| 2023 | 2.42 | ₹251.5 | ₹609.50 | ₹503 | Moderate |
| 2022 | 1.64 | ₹216.5 | ₹355.55 | ₹433 | Moderate |
LINCOLN vs Healthcare Peers — P/B Ratio Comparison
Lincoln Pharmaceuticals P/B 1.54 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹47 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |